Genomics is unlocking how DNA and viruses come together to shape chronic disease

Click here to view online. Add this email to your safelist.

28 January 2026

AstraZeneca and academic partners analysed genomic and health data from 750,000 people, the largest Epstein-Barr Virus (EBV) study to date, uncovering 20 genetic variants linked to high EBV levels and chronic disease risk. Learn more in our latest #WhatScienceCanDo story.

RSS Feed

Legal notice and Terms of Use

Cookie policy

Site map

For more information please visit astrazeneca.com.

If you would like to unsubscribe please click here.